Expression and immunoreactivity of HCV/HBV epitopes

World Journal of Gastroenterology

Volumn 11, Issue 41, 2005, Pages 6440-6444

  Xiong, Xin Yu ^a   Liu, Xiao ^a   Chen, Yuan Ding ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (China)

Author keywords

Epitope based vaccine; HBV; HCV; Immunoreactivity; Recombinant

Indexed keywords

CAPSID PROTEIN; EPITOPE; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; HEPATITIS C ANTIBODY; HEPATITIS C VACCINE;

ANTIBODY DETECTION; ARTICLE; BACTERIAL CELL; CONTROLLED STUDY; ESCHERICHIA COLI; GENE EXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; IMMUNOREACTIVITY; NONHUMAN; PROTEIN STRUCTURE; SENSITIVITY AND SPECIFICITY; STRUCTURE ANALYSIS; VIRUS ENVELOPE;

EID: 31344482362     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i41.6440     Document Type: Article

References (29)

1. Koff RS. Hepatitis vaccines: recent advances. Int J Parasitol 2003; 33: 517-523
2. El Khouri M, dos Santos VA. Hepatitis B: epidemiological, immunological, and serological considerations emphasizing mutation. Rev Hosp Clin Fac Med Sao Paulo 2004; 59: 216-224
3. Robertson B, Myers G, Howard C, Brettin T, Bukh J, Gaschen B, Gojobori T, Maertens G, Mizokami M, Nainan O, Netesov S, Nishioka K, Shini T, Simmonds P, Smith D, Stuyver L, Weiner A. Classification, nomenclature, and database development for HCV and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol 1998; 143: 2493-2503
4. Lindenbach BD, Rice CM. Flaviviridae: the viruses and their replication. In: D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.). Fields virology, 4th ed. Philadelphia, Pa. Lippincott Williams & Wilkins, 2001; 991-1042
5. Hadlock KG, Lanford RE, Perkins S, Rowe J, Yang Q, Levy S, Pileri P, Abrignani S, Foung SK. Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes. J Virol 2000; 74: 10407-10416
6. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995; 15: 41-62
7. Keck ZY, Op De Beeck A, Hadlock KG, Xia J, Li TK, Dubuisson J, Foung SK. Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions. J Virol 2004; 78: 9224-9232
8. Habersetzer F, Fournillier A, Dubuisson J, Rosa D, Abrignani S, Wychowski C, Nakano I, Trepo C, Desgranges C, Inchauspe G. Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties. Virology 1998; 249: 32-41
9. da Silva Cardoso M, Siemoneit K, Sturm D, Krone C, Moradpour D, Kubanek B. Isolation and characterization of human monoclonal antibodies against hepatitis C virus envelope glycoproteins. J Med Virol 1998; 55: 28-34
10. Burioni R, Plaisant P, Manzin A, Rosa D, Delli Carri V, Bugh F, Solforosi L, Abrignani S, Varaldo PE, Fadda G, Clementi M. Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments. Hepatology 1998; 28: 810-814
11. Allander T, Drakenberg K, Beyene A, Rosa D, Abrignani S, Houghton M, Widell A, Grillner L, Persson MA. Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81. J Gen Virol 2000; 81: 2451-2459
12. Gust ID, Burrell CJ, Coulepis AG, Robinson WS, Zuckerman AJ. Taxonomic classification of human hepatitis B virus. Intervirology 1986; 25: 14-29
13. Tisminetzky SG, Scodeller EA, Evangelisti P, Chen Y, Schiappacassi M, Porro F, Bizik F, Zacchi T, Lunazzi G, Miertus S. Immunoreactivity of chimeric proteins carrying the HIV-1 epitope IGPGRAF. Correlation between predicted conformation and antigenicity. FEBS Letters 1994; 353: 1-4
14. Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JW. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 1990; 185: 60-89
15. Chen YD, Liu MY, Yu WL, Li JQ, Peng M, Dai Q, Liu X, Zhou ZQ. Hepatitis C virus infections and genotypes in China. Hepatobiliary Pancreat Dis Int 2002; 1: 194-201
16. Chen YD, Liu MY, Yu WL, Li JQ, Peng M, Dai Q, Wu J, Liu X, Zhou ZQ. Sequence variability of the 5′ UTR in isolates of hepatitis C virus in China. Hepatobiliary Pancreat Dis Int 2002; 1: 541-552
17. Chen Y, Dai C. [Current status and strategy of research on epitope-based vaccine] Zhonghua Yu Fang Yi Xue Za Zhi. 1999; 33: 315-316
18. Bukh J, Purcell RH, Miller RH. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci U S A 1993; 90: 8234-8238
19. Gerin JL, Alexander H, Shih JW, Purcell RH, Dapolito G, Engle R, Green N, Sutcliffe JG, Shinnick TM, Lerner RA. Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees. Proc Natl Acad Sci U S A 1983; 80: 2365-2369
20. Moynihan JS, D'Mello FI, Howard CR. 48-mer synthetic peptide analogue of the hepatitis B virus "a" determinant induces an anti-HBs antibody response after a single injection. J Med Virol 2000; 62: 159-166
21. Stirk HJ, Thornton JM, Howard CR. A topological model for hepatitis B surface antigen. Intervirology 1992; 33: 148-158
22. Berting A, Hahnen J, Kroger M, Gerlich WH. Computer-aided studies on the spatial structure of the small hepatitis B surface protein. Intervirology 1995; 38: 8-15
23. Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 1995; 345: 1406-1407
24. Li Q, Dong C, Wang J, Che Y, Jiang L, Wang J, Sun M, Wang L, Huang J, Ren D. Induction of hepatitis C virus-specific humoral and cellular immune responses in mice and rhesus by artificial multiple epitopes sequence. Viral Immunol 2003; 16: 321-333
25. Chen YD, Xiong XY, Liu X, Li JQ, Wen YL, Chen YN, Dai Q, Cao ZL, Yu WL. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system. Mol Immunol 2006; 42: in press
26. Buratti E, Di Michele M, Song P, Monti-Bragadin C, Scodeller EA, Baralle FE, Tisminetzky SG. Improved reactivity of hepatitis C virus core protein epitopes in a conformational antigen-presenting system. Clin Diagn Lab Immunol 1997; 4: 117-121
27. Chen YD, Liu MY, Zou YJ, Peng M, Dai CB. Induction of neutralizing antibodies by SA11 Vp4-specific epitopes. Zhongguo Bing du xue 1997; 12: 125-131
28. Chen YD, Liu MY, Zhao W, Dai CB. Broadly Immunological Reactivities primed by epitopes corresponding to the cleavage region of SA11 Vp4. Zhongguo Bing du xue 1995; 13: 57-63
29. Liu X, Li JQ, Xiong XY, Chen YN, Peng M, Dai Q, Wen YL, Chen YD. [Protective efficacy of recombinant rotavirus epitope-based vaccine in mice] Zhongguo Yixue Kexueyuan Xue bao 2005; 27: 216-22